NCAPD3 and benign prostatic hyperplasia: Compared to human prostate stromal WPMY1 cells and benign prostatic hyperplasia BPH1 cells, all tumor cell lines (PC-3, DU 145, 22Rv1 and LNCaP) significantly increased NCAPD3 expression (Fig. 1F).